Corbus Pharmaceuticals Holdings Inc

NASDAQ:CRBP   9:31:27 AM EDT
1.08
0.00 (-0.46%)
Earnings Announcements

Corbus Pharmaceuticals Reports Q2 Results

Published: 08/12/2021 12:18 GMT
Corbus Pharmaceuticals Holdings Inc (CRBP) - Q2 Loss per Share $0.15.
Q2 Earnings per Share Estimate $-0.12 -- Refinitiv Ibes Data (analyst estimates).
Cash and Investments on Hand of $114 Million Provides Projected Runway Into Q1 of 2024.
Revenue is expected to be $0.89 Million
Adjusted EPS is expected to be -$0.12

Next Quarter Revenue Guidance is expected to be $1.01 Million
Next Quarter EPS Guidance is expected to be -$0.11

More details on our Analysts Page.